# Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India

> **NCT01108302** · NA · WITHDRAWN · sponsor: **Johns Hopkins Bloomberg School of Public Health**

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **OTHER:** Oxytocin in Uniject

## Key facts

- **NCT ID:** NCT01108302
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PATH withdrew IRB approval
- **Last updated:** 2012-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108302, "Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01108302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*